United States

Show stories from United States North America

News from aidsmap

  • Drug resistance in half of US patients overstated

    Keith Alcorn | 19 December 2001

    Over fifty per cent of Americans with HIV have drug-resistant virus, according to research presented at this week Interscience Conference on Antimicrobial and Antiviral . Highly educated white, middle class ...

  • "Moral failure" of leading nations attacked by UN representative

    Julian Meldrum | 13 December 2001

    Stephen Lewis, the Special Envoy of the UN Secretary General, Kofi Annan, on HIV/AIDS in Africa, delivered a blistering address to the closing ceremony of the 12th ICASA in Burkina ...

  • JAMA editorial endorses later treatment

    Keith Alcorn | 28 November 2001

    A further signal that US clinicians are being steered away from early treatment of HIV infection came today with the publication of an editorial in the Journal of the American Medical Association ...

  • Tipranavir development plans announced

    Keith Alcorn | 19 November 2001

    Boehringer-Ingelheim has announced further development plans for its protease inhibitor, tipranavir. Speaking at NAM’s symposium on Emerging Therapies for HIV Infection last Friday at the Royal College of Physicians in London, Dr ...

  • US backs down on generics for S Africa

    Michael Carter | 12 November 2001

    In the face of international and domestic pressure, the United States has conceded that South Africa and other developing countries can break international patent agreements to obtain cheaper versions of ...

  • Raised blood pressure more common in lipodystrophy

    Keith Alcorn | 06 November 2001

    Raised blood pressure is more common in HIV-positive people with lipodystrophy than either the general population or people with HIV without lipodystrophy, and tended to be associated with elevated triglyceride ...

  • Treating high cholesterol in HAART patients

    Keith Alcorn | 29 October 2001

    Controversy over the risk of heart disease in people on HAART continued at the Third International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV Infection last week, with competing ...

  • Tenofovir approved in Europe

    Keith Alcorn | 19 October 2001

    Tenofovir, the nucleotide analogue developed by Gilead, received scientific approval this week from the CPMP, the scientific advisory committee of the European Medicines Evaluation Agency, and is likely to be ...

Editors’ picks from other sources

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.